Stay updated with breaking news from Stuart Cohen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Developments are fast-moving as California and other states work to ramp up the COVID-19 vaccination effort. Here are answers to common questions about the vaccine that we have found from our coverage -- all in one place.
ZIP Advertisement COVID-19 Vaccine Questions: Can I test positive after getting the shot? What if Iâve already had COVID? Share Updated: 6:43 PM PST Jan 14, 2021 Share Updated: 6:43 PM PST Jan 14, 2021 Hide Transcript Show Transcript BE ADMINISTERED, PEOPLE IN THE COMMUNITY ARE SENDING IN QUESTIONS TO OUR NEWSROOM. KCRA 3âS BRITTANY JOHNSON IS TRACKING THEM. SHE SPOKE WITH AN INFECTIOUS DISEASE DOCTOR TO GET YOU ANSWERS. BRITTANY: AS ADDITIONAL PEOPLE BECOME ELIGIBLE TO RECEIVE THE VACCINE, WE RECEIVED MORE QUESTIONS. FIRST QUESTION -- CAN YOU TEST PO...
COVID-19 vaccines — in addition to saliva tests and sewage tests — will be covered at the UC Davis COVID Symposium on Wednesday, Jan. 13. The new addition to the panel is UC Davis Health physician Stuart Cohen, chief of the division of infectious diseases and director of the Hospital Epidemio
MONTREAL -- Distancing may seem to make parties impossible, especially in winter, but people found a way for Willie Glaser. Glaser, who turned 100 on Friday, fought for Canada in World War II and now lives in a retirement home in Saint-Laurent. On the front steps, he celebrated -- and he also got a pile of cards and a virtual party from students at the Hebrew Foundation School. Glaser has been dropping into the school for more than a decade to talk about his life, his time during the war, and the family members he lost in the Holocaust. "The students? They can learn so much from a ...
By Sasha Margulies, iHeart Media Jan 7, 2021 UC Davis is field testing a new vaccine to provide protection from COVID-19. Dr. Stuart Cohen with UC Davis Health says researchers are hoping to attract volunteers in communities hardest hit by the virus. The Novavax vaccine is different than others now on the market, as it uses pieces of the coronavirus to kick start the body's defense system. And the goal is to find up to 300 volunteers. In this double-blind study, two-thirds of the patients will receive the real vaccine and one-third will get a placebo.